Knocking down PKM2 or interrupting this loop with PKM2 inhibitors can inhibit the proinflammatory activity of microglia, restore their functional stability, reduce neuroinflammatory responses, improve AD pathology, and enhance patients’ learning and memory. This evidence concerns the gene PKM and Alzheimer disease.